Clinical Trials Logo

Osteoarthritis, Hip clinical trials

View clinical trials related to Osteoarthritis, Hip.

Filter by:

NCT ID: NCT03801265 Completed - Hip Osteoarthritis Clinical Trials

Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement

Start date: March 19, 2019
Phase: Phase 4
Study type: Interventional

The Lumbar Plexus (LP) block is currently used as the standard-of-care regional anesthesia technique to provide postoperative pain management after primary hip replacement surgery at UPMC Shadyside Hospital. However, the LP technique is complex and can be associated with potentially serious side effects, including nerve injury, major bleeding, retroperitoneal hematoma, and intrathecal injection of local anesthetic. In rare instances the LP block can also lead to motor blockade, interfering with early ambulation. There are several case reports of Quadratus Lumborum inter-fascial block (QL3) giving equally adequate pain relief after total hip replacement surgery, and this QL3 block is performed routinely at this institution. The benefits to inter-fascial administration of local anesthetic include the avoidance of theoretical nerve injury, bleeding and intrathecal anesthetic administration associated with the direct interaction between the nerve and the nerve block needle. The purpose of this study is to show that QL3 block is non-inferior to the standard-of-care lumbar plexus block and should be used more regularly in hip replacement surgery. The study will be conducted as a prospective, randomized (1:1), double-blind, non-inferiority, active-comparator trial. The investigators plan to enroll 40 subjects, 20 in each treatment group. This study will prospectively investigate the efficacy of QL3 versus Classic LP block for post-operative pain management in subjects undergoing primary, unilateral hip replacement surgery and prospectively compare QL3 versus Classic LP block in time to mobilization and physical therapy response. Primary outcome measures include pain at rest and with movement at 6, 12 and 24 hours after surgery. Secondary outcomes will be time for first request for pain medication, total pain medications (narcotics and non-narcotic analgesics) given in 24 hours and the time of participant's ability to walk 100 feet as recorded by a physical therapist.

NCT ID: NCT03793010 Terminated - Osteoarthritis, Hip Clinical Trials

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Start date: December 12, 2018
Phase: Phase 3
Study type: Interventional

This is a two-part, multi-center, randomized, double-blind, placebo-controlled, parallel-group study in patients with hip OA. Approximately 70 patients will be enrolled in Part I and approximately 440 patients will be enrolled in Part II of the study. In each part, patients will be randomized to one of two treatment groups (1:1) and treated with a single IA injection of either 32 mg FX006 or normal saline.

NCT ID: NCT03790306 Completed - Osteoarthritis, Hip Clinical Trials

Opioid Free and Therapy Minimized Advantages Using HANA Table for Total Hip Arthroplasty

Start date: January 15, 2019
Phase:
Study type: Observational

To prove that anterior approach total hip arthroplasty using the HANA table can be performed with little, if any, need for opioids using a combination of education, optimized pre op and post op pain protocols and optimized recovery tools.

NCT ID: NCT03785197 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Effects of a Clinical Dietary Intervention During Inpatient Treatment

FASTA
Start date: February 1, 2018
Phase:
Study type: Observational

The purpose of the study is a scientific and prospective documentation of the clinical effects of an inpatient treatment at the Immanuel Hospital of Berlin, in the department for complementary and integrative medicine, with the use of a modified fasting regime. A pre- and post- as well as group comparisons are planned. Patients that are admitted to the inpatient department for metabolic syndrome, osteoarthritis of the hip or knee, rheumatoid arthritis and fibromyalgia will be enrolled in the study.

NCT ID: NCT03783806 Recruiting - Hip Osteoarthritis Clinical Trials

Postural Control in Degenerative and Inflammatory Diseases of the Hip

PCHOAI
Start date: January 1, 2015
Phase:
Study type: Observational

Patients with primary hip osteoarthritis (OA group) and patients with inflammatory hip disease (RA group) and healthy subjects (control group) are enrolled in the study. The aim of our study is to determine the postural control in patients suffering from OA and RA of the hip joint during different conditions, i.e., on both stable and compliant surfaces with opened or closed eyes to determine the possible differences between these two diseases in this respect.

NCT ID: NCT03763760 Completed - Chronic Pain Clinical Trials

High-Dose Steroid for Hip Arthroplasty Patients Expected to Have Postoperative Pain

Start date: January 29, 2019
Phase: Phase 4
Study type: Interventional

The purpose of the Study is to test a higher dose of steroids(Dexamethasone) given just prior to surgery in the setting of Fast-Track Hip-surgery with Arthroplasty in a group of expected High Pain Responders and the effect on postoperative pain and postoperative inflammation.

NCT ID: NCT03744065 Completed - Pain, Postoperative Clinical Trials

Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement

Start date: November 19, 2018
Phase: N/A
Study type: Interventional

The nerves from lumbar plexus (LP) are the current target to achieve analgesia after a total hip arthroplasty (THA). Lumbar plexus block (LPB) is an alternative that provides optimal postoperative analgesia. However, many adverse effects and complications have been reported due to its proximity to vital structures. Because of these shortcomings, an alternative to block the LP nerves is required. In a recent trial suprainguinal Fascia Iliaca Block (SFIB) was reported to provide reliable analgesia in THA. SFIB may carry a lower risk profile, however, no study has compared the efficacy of LPB and SFIB in this setting. Thus, this randomized trial is set out to compare US guided LPB and SFIB for analgesia after THA. The hypothesis is that both blocks would result in similar postoperative opioid (morphine) consumption at 24 hours and, therefore, designed the study as an equivalence trial.

NCT ID: NCT03737149 Active, not recruiting - Clinical trials for Osteoarthritis, Knee

A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform

Start date: October 22, 2018
Phase: N/A
Study type: Interventional

Post-market prospective, multi-center longitudinal study to determine if mobile application-guided education and exercise paired with accurate and sensitive activity monitoring, captured from consumer wearables, can provide a viable (and potentially improved) alternative to current standard of care physical therapy for hip and knee arthroplasty.

NCT ID: NCT03711773 Recruiting - Osteoarthritis Clinical Trials

Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

The primary objective of this study is to study how low-impact group exercise classes affect pain scores in patients with knee, hip, and ankle pain when paired with concurrent standard of care dietitian and behavioral health consults.

NCT ID: NCT03702595 Completed - Hip Osteoarthritis Clinical Trials

Effects of a Stretching Protocol in Patients With Hip Osteoarthritis

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Clinical guidelines recommend non-pharmacological conservative treatments for the management of OA. Hip flexors seems to play an important role in the development of hip OA but there is no published studies evaluating the results of a stretching protocol of hip flexors in hip OA patients. The objective of this trial is to evaluate if a stretching protocol of hip flexors is more effective in symptoms, functional capacity , range of motion, strength, muscular length, pain threshold and anxiety and depression compared to control. For this purpose the investigators conduct a single-group, pretest-posttest clinical trial.The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence. The variables are measured at the beginning and at the end of treatment of the control phase, and at the end of the stretching protocol phase.